Loncar China BioPharma ET... (CHNA)
NASDAQ: CHNA
· Real-Time Price · USD
13.53
-0.01 (-0.07%)
At close: Oct 17, 2023, 7:51 PM
-0.07% (1D)
| Bid | - |
| Market Cap | 0 |
| AUM | 9.97M |
| NAV | 9.77 |
| EPS (ttm) | 0.00 |
| PE Ratio (ttm) | n/a |
| Shares Out | 0 |
| Inception Date | Aug 15, 2018 |
| Ask | - |
| Volume | 9 |
| Open | 14.30 |
| Previous Close | 13.54 |
| Day's Range | 13.53 - 14.30 |
| 52-Week Range | 9.77 - 22.89 |
| Holdings | 57 |
| Expense Ratio | 0.79% |
About CHNA
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
Asset Class Equity
Ticker Symbol CHNA
Inception Date Aug 15, 2018
Provider Other
Website Fund Home Page
Exchange NASDAQ
Dividends Dividend Yield 0.33%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Oct 16, 2023 | $0.0487 | Oct 18, 2023 |
| Dec 29, 2021 | $3.0314 | Dec 31, 2021 |
| Dec 30, 2020 | $0.1546 | Jan 4, 2021 |
| Dec 23, 2019 | $0.0402 | Dec 26, 2019 |
1 year ago · seekingalpha.com
Why China May Need To Do More To Boost Investor ConfidenceWhy China May Need To Do More To Boost Investor Confidence
